New Pill From Merck Could Slash Cholesterol Levels, Trials Show

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

Experimental daily pill may lower cholesterol in patients who don’t see enough benefit with statins alone, study finds

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications may not be sufficient in helping them reach their target cholesterol levels.
The American Journal of Managed Care

Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol

Navar A. Efficacy and safety of enlicitide, an oral PCSK9 inhibitor, for lowering LDL cholesterol in adults with or at-risk for ASCVD: the phase 3 CORALreef lipids trial. Presented at: AHA 2025 ...
Daily Voice on MSN

New Pill Lowers High Cholesterol By 60 Percent, Merck Says

Merck has unveiled a groundbreaking cholesterol-lowering pill, enlicitide, which could transform treatment for millions of Americans struggling with high LDL cholesterol. The once-daily oral ...